New SPAC on the Block: Drugs Made In America Acquisition II Files for $500M IPO Amid Pharma Nationalization Push
Fort Lauderdale, FL | July 21, 2025 —
In a bold bet on the reshoring of American pharmaceutical manufacturing, Drugs Made In America Acquisition II Corp (Nasdaq: DMIIU) filed...
Figma Files for $1 Billion IPO Amid Soaring Growth and Strategic Reset
Design platform eyes $16.4 billion valuation as it steps into public markets post-Adobe deal collapse
Figma, the browser-based collaborative design platform, has officially filed terms...
Robot Consulting Co., Ltd. (LAWR) IPO: Japanese HR-Tech Firm Raises $15 Million in Nasdaq Debut
On July 16, 2025, Robot Consulting Co., Ltd., a Tokyo-based HR-tech innovator, priced its initial public offering on the Nasdaq Capital Market under the ticker LAWR,...
CARLSMED, Inc. (CARL) IPO: Medical Innovation Company Launches Nasdaq Global Select Offering
CARLSMED, Inc. has filed to go public on the Nasdaq Global Select Market under the symbol CARL, announcing an initial offering priced between $14.00 and $16.00...
Bullish Goes Public: Crypto Powerhouse Files $100M US IPO Amid Market Shift
Strategic IPO Push: Bullish Eyes NYSE Listing under “BLSH”
Bullish, the institutional-grade digital asset platform backed by Peter Thiel and other heavyweights, filed for a...
